A Carbamic acid, ester with choline chloride CEP of the European Pharmacopoeia monograph is often referred to as a Carbamic acid, ester with choline chloride Certificate of Suitability (COS). The purpose of a Carbamic acid, ester with choline chloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbamic acid, ester with choline chloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbamic acid, ester with choline chloride to their clients by showing that a Carbamic acid, ester with choline chloride CEP has been issued for it. The manufacturer submits a Carbamic acid, ester with choline chloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbamic acid, ester with choline chloride CEP holder for the record. Additionally, the data presented in the Carbamic acid, ester with choline chloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbamic acid, ester with choline chloride DMF.
A Carbamic acid, ester with choline chloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbamic acid, ester with choline chloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbamic acid, ester with choline chloride suppliers with CEP (COS) on PharmaCompass.